1. Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3.
- Author
-
Boero E, Cruz AR, Pansegrau W, Giovani C, Rooijakkers SHM, van Kessel KPM, van Strijp JAG, Bagnoli F, and Manetti AGO
- Subjects
- Humans, Immunoglobulin G, Opsonin Proteins, Phagocytosis, Staphylococcus, Staphylococcus aureus, Staphylococcal Infections, Staphylococcal Protein A
- Abstract
Staphylococcal protein A (SpA) is a multifunctional, highly conserved virulence factor of Staphylococcus aureus . By binding the Fc portion of all human IgG subclasses apart from IgG3, SpA interferes with antibody and complement deposition on the bacterial surface, impairing staphylococcal clearance by phagocytosis. Because of its anti-opsonic properties, SpA is not investigated as a surface antigen to mediate bacterial phagocytosis. Herein we investigate human sera for the presence of SpA-opsonizing antibodies. The screening revealed that sera containing IgG3 against SpA were able to correctly opsonize the target and drive Fcγ receptor-mediated interactions and phagocytosis. We demonstrated that IgG3 Fc is significantly more efficient in inducing phagocytosis of SpA-expressing S. aureus as compared to IgG1 Fc in an assay resembling physiological conditions. Furthermore, we show that the capacity of SpA antibodies to induce phagocytosis depends on the specific epitope recognized by the IgGs on SpA molecules. Overall, our results suggest that anti-SpA IgG3 antibodies could favor the anti-staphylococcal response in humans, paving the way towards the identification of a correlate of protection against staphylococcal infections., Competing Interests: EB is participating in a post-graduate studentship program at GSK. All authors affiliated with GSK are employees of GSK, Siena. FB holds pending and issued patents on S. aureus vaccine formulations. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Boero, Cruz, Pansegrau, Giovani, Rooijakkers, van Kessel, van Strijp, Bagnoli and Manetti.)
- Published
- 2022
- Full Text
- View/download PDF